Project List
List projects.
Fields
id (integer)
Primary key.
Expansions
To activate relation expansion add the desired fields as a comma separated
list to the expand query parameter like this:
?expand=<field>,<field>,<field>,...
The following relational fields can be expanded:
organizationcategorytypepartner_functionmanagercontactstatusgrantresearcheventstudylanguageprogramfunders
Filters
To filter for exact value matches:
?<fieldname>=<value>
Possible exact filters:
organizationcategorymanagercontactstatusgrantresearchstudylanguagefundersprogram
For advanced filtering use lookups:
?<fieldname>__<lookup>=<value>
All fields with advanced lookups can also be used for exact value matches as described above.
Possible advanced lookups:
begin_planned:gt,gte,lt,ltebegin_effective:gt,gte,lt,lteend_planned:gt,gte,lt,lteend_effective:gt,gte,lt,lte
GET /v1/research/project/?format=api&offset=1060&ordering=end_effective
{ "count": 2265, "next": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=1080&ordering=end_effective", "previous": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=1040&ordering=end_effective", "results": [ { "id": 4445, "title": { "de": "1.1 - Clinical information systems for biobanks - CBmed", "en": "1.1 - Clinical information systems for biobanks - CBmed" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2015-07-01T02:00:00+02:00", "begin_effective": "2015-07-01T02:00:00+02:00", "end_planned": "2018-12-31T01:00:00+01:00", "end_effective": "2018-12-31T01:00:00+01:00", "assignment": "2016-05-13T13:29:26+02:00", "program": null, "subprogram": null, "organization": 23613, "category": 10, "type": 10, "partner_function": 4, "manager": 54142, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 416 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "4445-54142-10" ] }, { "id": 5014, "title": { "de": "Forschungen zu Infektionserkrankungen bei Kindern im Rahmen der Projekte\r\n„EU-TICK.BO“, „RNA-Sequenzierung bei akuter Faszialisparese“ sowie „Beschreibung des\r\nMasernausbruches 2017“", "en": "EU-Tick-BO, RNA sequencing in acute facial palsy, and measles outbreak in Styria" }, "short": "Eutickbo", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2017-07-01T02:00:00+02:00", "begin_effective": "2017-07-01T02:00:00+02:00", "end_planned": "2018-06-30T02:00:00+02:00", "end_effective": "2018-12-31T01:00:00+01:00", "assignment": "2017-07-17T12:39:38+02:00", "program": null, "subprogram": null, "organization": 14091, "category": 10, "type": 10, "partner_function": 4, "manager": 51647, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "5014-51647-10" ] }, { "id": 2751, "title": { "de": "Pollen-Enzyme schädigen menschliche Tränenflüssigkeit und Zellen der Augenoberfläche - Ein Ansatz zum Verständnis des SNAK (saisonale nicht-allergische Konjunktivitis)-Syndroms.", "en": "Pollen enzymes degrade human tear fluid and cells of the ocular surface - an approach for understanding the SNAC (saisonal non-allergic conjunctivitis) syndrome." }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-12-01T01:00:00+01:00", "begin_effective": "2012-02-01T01:00:00+01:00", "end_planned": "2014-09-30T02:00:00+02:00", "end_effective": "2018-12-31T01:00:00+01:00", "assignment": "2012-01-18T13:48:45+01:00", "program": null, "subprogram": null, "organization": 14043, "category": 10, "type": 10, "partner_function": 4, "manager": null, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 938 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 5273, "title": { "de": "Erstellung eines Registers zur Erfassung von Patienten mit einer terminalen Herzinsuffizienz in der Steiermark", "en": "Establishment of a styrian end- stage heart failure registry " }, "short": "Styrian end-stage heart failure registry", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2018-01-01T01:00:00+01:00", "begin_effective": "2018-01-01T01:00:00+01:00", "end_planned": "2018-12-31T01:00:00+01:00", "end_effective": "2018-12-31T01:00:00+01:00", "assignment": "2018-02-20T10:55:08+01:00", "program": null, "subprogram": "Kulturamt Stadt Graz", "organization": 14075, "category": 10, "type": 10, "partner_function": 4, "manager": null, "contact": null, "status": 2, "research": 4, "grant": 20, "event": null, "study": null, "language": null, "funders": [ 457 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 3478, "title": { "de": "Proposal for Establishing a National Hub of the European Biobanking and Biomolecular Resources Research Infrastructure BBMRI-ERIC", "en": "Antrag zur Etablierung eines Nationalen Knotens der Europäischen Forschungsinfrastruktur für Biobanken und Biomolekulare Ressourcen" }, "short": "BBMRI.AT", "url": null, "abstract": { "de": "Die systematische Analyse von biologischen Proben und medizinischen Daten bildet seit\r\nJahrhunderten die Grundlage unseres Wissens über Krankheitsursachen und der Entwicklung neuer\r\nDiagnosemethoden, Medikamente und Therapien. Biologische Proben und Daten werden daher auch\r\nals die Schlüsselressource für den Fortschritt in Medizin und Biotechnologie gesehen (OECD 2001).\r\nDie nachhaltige Erschließung dieser Schlüsselressourcen soll durch die pan‐europäische\r\nForschungsinfrastruktur BBMRI‐ERIC mit dem Hauptquartier in Graz/Österreich sichergestellt\r\nwerden. Die österreichische wissenschaftliche Beteiligung an BBMRI‐ERIC erfolgt durch ein nationales\r\nNetzwerk (BBMRI.AT), das eng mit dem europäischen Hauptquartier zusammenarbeiten soll und die\r\nöffentlichen medizinischen Universitäten Österreichs, die Alpen Adria Universität Klagenfurt, die\r\nveterinärmedizinische Universität Wien und das Wiener Life Science Governance Institute als\r\nPartner vorsieht.\r\nDas Arbeitsprogramm von BBMRI.AT wird sich auf folgende Bereiche konzentrieren:\r\n Etablierung des österreichischen nationalen Knotens und die Vertretung des Knotens im BBMRIERIC\r\nManagement Komitee entsprechend den Statuten und des Businessplans von BBMRI‐ERIC;\r\n Optimale Harmonisierung der Prozesse innerhalb von BBMRI.AT, um die bestehenden Biobanken\r\nin eine nationale Forschungsinfrastruktur zu integrieren;\r\n Optimale Harmonisierung der Prozesse von BBMRI.AT mit denen von BBMRI‐ERIC, um die\r\ninternationale Sichtbarkeit und Bedeutung der österreichischen Biobanken und damit\r\nzusammenhängender Forschung zu erhöhen;\r\n Weiterentwicklung der österreichischen Stärken im Bereich von im Gesundheitssystem\r\nintegrierten Biobanken, um ein führender Partner für akademische und industrielle Forschung zu\r\nwerden.\r\n Verankerung von BBMRI.AT im gesellschaftlichen Umfeld unter Einbeziehung der öffentlichen\r\nErwartungshaltungen und ethisch/rechtliche Gegebenheiten.", "en": "Since centuries the systematic investigation of biological samples and medical data provides the\r\nfoundation for our knowledge on diseases and the development of new diagnostic procedures,\r\nmedications, and therapies. Therefore, biological samples are considered as the key resource for the\r\nadvancement of medicine and biotechnology (OECD 2001). The sustainable exploration of this key\r\nresource should be assured by the pan‐European research infrastructure BBMRI‐ERIC with its\r\nstatutory seat and executive management office in Graz/Austria. The scientific participation of\r\nAustria in BBMRI‐ERIC is exerted by a national node (BBMRI.AT) which should closely collaborate\r\nwith the central executive management office, and involves the Austrian public medical universities,\r\nthe Alpen Adria University Klagenfurt, the University of Veterinary Medicine Vienna, and the Life\r\nScience Governance Institute.\r\nThe work programme will focus on the following topics:\r\n Establishment of the Austrian national node and representation of the national node in the\r\nBBMRI‐ERIC management committee according to the statutes and business plan of BBMRI‐ERIC;\r\n Optimal harmonization of procedures within BBMRI.AT to integrate existing biobanks into a\r\nnational research infrastructure;\r\n Optimal harmonization of BBMRI.AT procedures with BBMRI‐ERIC to increase international\r\nvisibility and the role of Austrian biobanks and related research;\r\n Further development of the Austrian strengths in health care integrated biobanking to become a\r\nleading partner for academic and industrial research.\r\n Embedding BBMRI.AT into the societal framework by relating BBMRI.AT to societal expectations\r\nand ethical/legal requirements" }, "begin_planned": "2013-11-01T01:00:00+01:00", "begin_effective": "2013-12-01T01:00:00+01:00", "end_planned": "2018-09-30T02:00:00+02:00", "end_effective": "2018-12-31T01:00:00+01:00", "assignment": "2013-12-19T16:17:04+01:00", "program": 90, "subprogram": null, "organization": 14020, "category": 10, "type": 10, "partner_function": 3, "manager": 51663, "contact": null, "status": 2, "research": 5, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 25 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "3478-51870-12", "3478-51663-10" ] }, { "id": 4113, "title": { "de": "Zelluläre Immunrekonstitution gegenüber relevanter humanpathogener Viren bei Kindern und Jugendlichen nach allogener Stammzelltransplantation", "en": "Cellular immunereconstitution against relevant viral human pathogens after allogeneic stem cell transplantation in children and adolescents" }, "short": "CIRAST -Virusspez. Immunität nach SCT", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2015-11-01T01:00:00+01:00", "begin_effective": "2016-11-01T01:00:00+01:00", "end_planned": "2017-02-28T01:00:00+01:00", "end_effective": "2018-12-31T01:00:00+01:00", "assignment": "2015-10-06T12:10:37+02:00", "program": 81, "subprogram": null, "organization": 14092, "category": 10, "type": 10, "partner_function": 4, "manager": 56810, "contact": null, "status": 2, "research": 4, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1550 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "4113-91769-12", "4113-56810-10" ] }, { "id": 3915, "title": { "de": "Dysregulation von extrazellulärer Matrix in verschiedenen Formen pulmonaler Hypertonie", "en": "Extracellular matrix dysregulation in different forms of pulmonary hypertension " }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2014-07-01T02:00:00+02:00", "begin_effective": "2015-03-01T01:00:00+01:00", "end_planned": "2017-06-30T02:00:00+02:00", "end_effective": "2018-12-31T01:00:00+01:00", "assignment": "2015-02-26T14:23:51+01:00", "program": 79, "subprogram": null, "organization": 14010, "category": 10, "type": 10, "partner_function": 4, "manager": 82090, "contact": null, "status": 2, "research": 5, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 12 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "3915-61540-12", "3915-82090-10" ] }, { "id": 4491, "title": { "de": "Early Detection of Trastuzumab induced Cardiotoxicity with novel Biomarkers and Identification of protective Co-treatments", "en": "Early Detection of Trastuzumab induced Cardiotoxicity with novel Biomarkers and Identification of protective Co-treatments" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2016-06-01T02:00:00+02:00", "begin_effective": "2016-06-01T02:00:00+02:00", "end_planned": "2017-12-31T01:00:00+01:00", "end_effective": "2018-12-31T01:00:00+01:00", "assignment": "2016-06-15T14:41:57+02:00", "program": null, "subprogram": null, "organization": 14083, "category": 10, "type": 10, "partner_function": 4, "manager": 58906, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 140 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "4491-96882-12", "4491-58906-10" ] }, { "id": 3852, "title": { "de": "Aufklärung der spezifischen Zytotoxizität von Dimethylacrylshikonin in Melanomzellen", "en": "Elucidation of specific cytotoxic effects of dimethylacrylshikonin in melanoma cells" }, "short": "SpeDiMel", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2015-01-01T01:00:00+01:00", "begin_effective": "2015-01-28T01:00:00+01:00", "end_planned": "2018-01-01T01:00:00+01:00", "end_effective": "2019-01-27T01:00:00+01:00", "assignment": "2015-01-09T09:19:54+01:00", "program": 72, "subprogram": null, "organization": 17218, "category": 10, "type": 10, "partner_function": 2, "manager": 50826, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "P27505", "ethics_committee": null, "edudract_number": null, "persons": [ "3852-50826-10" ] }, { "id": 4316, "title": { "de": "Relaxin", "en": "Relaxin" }, "short": "RELAXIN", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2016-05-01T02:00:00+02:00", "begin_effective": "2016-08-01T02:00:00+02:00", "end_planned": "2018-04-30T02:00:00+02:00", "end_effective": "2019-01-31T01:00:00+01:00", "assignment": "2016-02-17T10:16:51+01:00", "program": 60, "subprogram": null, "organization": 14073, "category": 10, "type": 10, "partner_function": 4, "manager": 50874, "contact": null, "status": 2, "research": 3, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 416 ], "funder_projectcode": "853276", "ethics_committee": null, "edudract_number": null, "persons": [ "4316-98584-12", "4316-50874-10", "4316-62756-12", "4316-81091-12", "4316-108983-12" ] }, { "id": 3738, "title": { "de": "Potentielle positive Effekte von intestinaler ATGL Überexpression", "en": "Potential beneficial effects of intestinal ATGL overexpression" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2015-01-01T01:00:00+01:00", "begin_effective": "2015-01-01T01:00:00+01:00", "end_planned": "2017-12-31T01:00:00+01:00", "end_effective": "2019-01-31T01:00:00+01:00", "assignment": "2014-08-07T12:28:43+02:00", "program": 72, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": 51904, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "P 27070", "ethics_committee": null, "edudract_number": null, "persons": [ "3738-51904-10" ] }, { "id": 4512, "title": { "de": "Kontrolle des Ansprechens auf neoadjuvante Therapie bei Brustkrebspatientinnen anhand von Plasma-DNA", "en": "Clinical utility of plasma-DNA to monitor response to neoadjuvant therapy in breast cancer patients\r\n" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2016-08-01T02:00:00+02:00", "begin_effective": "2016-08-01T02:00:00+02:00", "end_planned": "2019-01-31T01:00:00+01:00", "end_effective": "2019-01-31T01:00:00+01:00", "assignment": "2016-07-11T16:41:21+02:00", "program": 79, "subprogram": null, "organization": 14021, "category": 10, "type": 10, "partner_function": 4, "manager": 50899, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 12 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "4512-50899-10" ] }, { "id": 3413, "title": { "de": "Verhaltensstörungen nach viszeraler Immunaktivierung", "en": "Psychopharmacology of the Visceral Immune Brain Axis" }, "short": "Immune-Brain Axis", "url": null, "abstract": { "de": "Depression ist eine der häufigsten und schwersten affektiven Störungen, welche die Lebensqualität und Arbeitsfähigkeit der betroffenen Patienten massiv einschränkt und damit von enormer sozio-ökonomischer Bedeutung ist. Die Weltgesundheitsorganisation berichtet, dass Depression in der Altersklasse von 15 44 Jahren schon jetzt bei beiden Geschlechtern die zweithäufigste Ursache für disability adjusted life years darstellt und die Zahl der von Depression betroffenen Patienten weiter steigt. Unglücklicherweise sprechen bis zu 40 % der Patienten mit Depression nur unzureichend auf die verfügbaren Antidepressiva an, was mit der Tatsache zusammenhängt, dass die Ätiologie affektiver Störungen nur unvollständig bekannt ist. Abgesehen von genetischen und psychosozialen Risikofaktoren rückt immer mehr auch eine chronische Stimulierung des Immunsystems als eine Ursache für die Entstehung affektiver Störungen in den Blickpunkt. Die Zytokin-Hypothese der Depression postuliert, dass systemische Immunprozesse über erhöhte Blutspiegel proinflammatorischer Zytokine einen Einfluss auf Gehirnfunktionen ausüben, die Ängstlichkeit, Affekt, Stressresistenz und kognitive Prozesse regulieren.\r\nAktivierung des viszeralen Immunsystems und viszerale Entzündung können mit einer Reihe von psychiatrischen Abnormalitäten assoziiert sind. Klinische Beobachtungen sprechen dafür, dass Translokation von Zellwandkomponenten des intestinalen Mikrobioms über eine pathologisch durchlässige Darmschleimhaut zu affektiven Störungen führen kann. Präklinische Befunde belegen, dass gastrointestinale Infektionen, gastrointestinale Entzündungen und intraperitoneale Verabreichung bakteriellen Endotoxins emotional-affektive Verhaltensänderungen auslöst. Vor diesem Hintergrund ist es das Ziel des vorgelegten Projekts, in einem experimentellen Ansatz depressive Verhaltensänderungen nach viszeraler Immunstimulierung in umfassender und innovativer Weise zu analysieren und neue Angriffspunkte für wirksame pharmakologische Interventionen zu identifizieren.\r\nDie wichtigsten Hypothesen, die es zu untersuchen gilt, sind, \r\n\tdass Zellwandkomponenten des intestinalen Mikrobioms (Lipopolysaccharid, Pepidoglycan) und intestinale Hormone unter dem Einfluss des Mikrobioms (Glucagon-Like Peptide, Peptid YY) depressive Verhaltensänderungen hervorrufen,\r\n\tviszerale Immunaktivierung das affektive Verhalten kurz- und langfristig beeinflusst;\r\n\tspezifische Signaltransduktionsmechanismen im Gehirn (Receptor-Activator of Nuclear Factor B Ligand, Cyclooxygenase-2 und Brain-Derived Neurotrophic Factor) von Relevanz für die affektiven Störungen im Gefolge einer peripheren Immunaktivierung sind, und\r\n\tdepressive Verhaltensänderungen nach viszeraler Immunstimulierung mit einer Störung der Hypothalamus-Hypophysen-Nebennieren-Achse, einer Störung des Glukokortikoid-Feedback an das Gehirn und einer Störung der Neurogenese im limbischen System assoziiert sind.", "en": "Being one of the most prevalent and severe mood disorders, major depression is deleterious to the patients quality of life and of enormous socio-economic impact. According to the World Health Organization, depression is the second most frequent cause of disability-adjusted life years in the age category of 15 44 years for both genders, with the number of patients continuing to grow. A proportion of some 40 % of the patients does not satisfactorily respond to the available antidepressant drugs, which reflects the incomplete understanding of the aetiology of affective disorders. Apart from vulnerability and psychosocial factors, chronic immune challenge has emerged as a circumstance relevant to the pathogenesis of mood disorders. The cytokine hypothesis of depression holds that systemic inflammatory processes associated with elevated levels of circulating proinflammatory cytokines disturb several brain mechanisms that control anxiety, mood, stress resilience and cognition.\r\nVisceral immune activation and inflammation are associated with a variety of psychiatric abnormalities, and there is clinical evidence that constituents of the intestinal microbiota across a leaky mucosal barrier may be a factor underlying mood disorders. Preclinical evidence indicates that gastrointestinal infection and inflammation as well as intraperitoneal administration of bacterial lipopolysaccharide induce behavioural disturbances. The current research proposal sets out to specifically examine the visceral immune brain axis in an innovative and comprehensive manner and to identify key mechanisms that are suitable for pharmacological modulation.\r\nThe main hypotheses to be addressed are that\r\n\tfactors derived from the intestinal microbiota (lipopolysaccharide, pepidoglycan) or intestinal hormones under the regulatory influence of the microbiota (glucagon-like peptide, peptide YY) have an impact on the visceral immune brain axis;\r\n\tvisceral immune challenge has a short- and long-term impact on affective behaviour;\r\n\tspecific brain signalling mechanisms involving receptor-activator of nuclear factor B ligand, cyclooxygenase-2 and brain-derived neurotrophic factor play a role in the behavioural effects of peripheral immune challenge; and\r\n\tactivation of the visceral immune brain axis is associated with deranged activity of the hypothalamic-pituitary-adrenal axis, disturbed glucocorticoid feedback on the brain and altered neurogenesis in the limbic system." }, "begin_planned": "2013-10-01T02:00:00+02:00", "begin_effective": "2014-02-01T01:00:00+01:00", "end_planned": "2016-09-30T02:00:00+02:00", "end_effective": "2019-01-31T01:00:00+01:00", "assignment": "2013-10-25T11:06:48+02:00", "program": 72, "subprogram": null, "organization": 14022, "category": 10, "type": 10, "partner_function": 4, "manager": 51529, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "P25912", "ethics_committee": null, "edudract_number": null, "persons": [ "3413-71386-12", "3413-71487-12", "3413-77692-12", "3413-51529-10" ] }, { "id": 3854, "title": { "de": "Die Prävalenz von FHH bei PatientInnen mit einem primären Hyperparathyreoidismus", "en": "The Prevalence of FHH in Patients with Primary Hyperparathyroidism" }, "short": "EPATH-FHH", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2014-07-01T02:00:00+02:00", "begin_effective": "2015-02-01T01:00:00+01:00", "end_planned": "2014-02-01T01:00:00+01:00", "end_effective": "2019-01-31T01:00:00+01:00", "assignment": "2015-01-13T10:13:03+01:00", "program": null, "subprogram": null, "organization": 14083, "category": 10, "type": 10, "partner_function": 4, "manager": 81519, "contact": null, "status": 2, "research": 4, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1565 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "3854-81519-10" ] }, { "id": 3265, "title": { "de": "HOMAGE", "en": "HOMAGE" }, "short": "HOMAGE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2012-11-01T01:00:00+01:00", "begin_effective": "2013-02-01T01:00:00+01:00", "end_planned": "2017-10-30T01:00:00+01:00", "end_effective": "2019-01-31T01:00:00+01:00", "assignment": "2013-05-13T17:29:05+02:00", "program": 24, "subprogram": null, "organization": 14083, "category": 10, "type": 10, "partner_function": 2, "manager": null, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": "305507", "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 4256, "title": { "de": "The functional role of HDL in the tumor microenvironment", "en": "The functional role of HDL in the tumor microenvironment" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2015-02-01T01:00:00+01:00", "begin_effective": "2015-02-01T01:00:00+01:00", "end_planned": "2018-01-31T01:00:00+01:00", "end_effective": "2019-01-31T01:00:00+01:00", "assignment": "2016-01-28T12:53:45+01:00", "program": 69, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": null, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "J3664-B19", "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 3809, "title": { "de": "Funktionalität ex vivo generierter Retikulozyten aus humanen Stammzellen", "en": "Functional quality of reticulocytes generated ex vivo from human stem cells" }, "short": "Ex vivo generated Reticulocytes", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2015-01-01T01:00:00+01:00", "begin_effective": "2015-01-01T01:00:00+01:00", "end_planned": "2019-02-28T01:00:00+01:00", "end_effective": "2019-02-08T01:00:00+01:00", "assignment": "2014-11-14T14:34:34+01:00", "program": null, "subprogram": null, "organization": 14058, "category": 10, "type": 10, "partner_function": 4, "manager": 88593, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1586 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "3809-51164-12", "3809-88593-10", "3809-93640-12", "3809-51910-12", "3809-50131-12" ] }, { "id": 3489, "title": { "de": "BIOBANKING AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE AUSTRIA", "en": "BIOBANKING AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE AUSTRIA" }, "short": "BBMRI.AT", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2013-12-01T01:00:00+01:00", "begin_effective": "2013-12-01T01:00:00+01:00", "end_planned": "2018-11-30T01:00:00+01:00", "end_effective": "2019-02-28T01:00:00+01:00", "assignment": "2014-01-07T14:19:47+01:00", "program": 90, "subprogram": null, "organization": 14017, "category": 10, "type": 10, "partner_function": 2, "manager": 54142, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 25 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "3489-54142-10" ] }, { "id": 4793, "title": { "de": "Lipasen und Lipidsignaling ", "en": "Lipases and Lipid Signaling" }, "short": "BioTechMed", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2017-03-01T01:00:00+01:00", "begin_effective": "2017-03-01T01:00:00+01:00", "end_planned": "2019-02-28T01:00:00+01:00", "end_effective": "2019-02-28T01:00:00+01:00", "assignment": "2017-01-02T11:28:55+01:00", "program": null, "subprogram": "BioTechMed Flagship Project", "organization": 14038, "category": 10, "type": 10, "partner_function": 2, "manager": 50442, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2325 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "4793-50442-10" ] }, { "id": 3691, "title": { "de": "Placenta Perfusion Studio", "en": "Placenta Perfusion Studio" }, "short": "Plazentatox", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2014-09-01T02:00:00+02:00", "begin_effective": "2014-09-01T02:00:00+02:00", "end_planned": "2018-08-30T02:00:00+02:00", "end_effective": "2019-02-28T01:00:00+01:00", "assignment": "2014-06-26T13:30:26+02:00", "program": 107, "subprogram": null, "organization": 14038, "category": 10, "type": 10, "partner_function": 4, "manager": 50442, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 416 ], "funder_projectcode": "844741", "ethics_committee": null, "edudract_number": null, "persons": [ "3691-88993-12", "3691-50442-10", "3691-56938-12", "3691-83661-12", "3691-89898-12", "3691-90214-12", "3691-51632-12", "3691-100813-12" ] } ] }